abstract |
The invention relates to a pharmaceutical preparation comprising a mixture of non-reducing sugar, a recombinant humanized anti-Her2 monoclonal antibody-MMAE conjugate, and a surfactant. The pharmaceutical preparation has the characteristics of reducing particulate matter, reducing aggregate formation, improving conjugate stability, improving appearance of lyophilized powder, and the like. |